创新的多元组件数字护理助理和支持计划,用于中风或短暂缺血性发作后的人:试点可行性研究
Liam P Allan1,2, David Silvera-Tawil2, Jan Cameron1,3
1Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Victorian Heart Institute, Monash University, Clayton, VIC 3168, Australia.
Sensors (Basel, Switzerland)
|November 27, 2024
概括
对中风的护理助理和支持计划 (CAPS) 证明了二次中风预防的可行性. 这个数字健康计划显示了高度的保留,可用性和参与者参与自我监测和目标实现的参与度.
科学领域:
- 数字健康数字健康
- 脑卒中康复治疗 脑卒中康复治疗
- 二次预防 二次预防
背景情况:
- 越来越多的证据支持用于二次中风预防的数字健康干预措施.
- 脑卒中护理助理和支持计划 (CAPS) 是一个新的数字计划,结合了目标设定和风险因素监测.
研究的目的:
- 确定CAPS计划对中风后或短暂性缺血性发作 (TIA) 患者的可行性.
- 评估招聘,留住,可用性,可接受性和对CAPS计划的满意度.
主要方法:
- 一个为期12周的混合方法,开放的可行性研究.
- 参与者使用网络门户,短信,移动应用程序和可穿戴设备来设定目标和监控.
- 可行性结果包括招聘,保留,可用性,可接受性和满意度.
主要成果:
- 实现了高招聘率 (94%) 和保留率 (97%).
- 移动应用程序表现出良好的至优秀的可用性,其中94%的人同意它有助于自我监控.
- 在自我效能,心血管健康和心理健康方面观察到显著的改善.
结论:
- 该CAPS计划是可行的,可接受的,并参与二次中风预防.
- 需要在随机对照试验中进行进一步评估.
- 数字健康为中风后护理提供了一个有希望的途径.
更多相关视频
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
1.1K
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
496
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
